Hydroxyurea vs placeboPain alterationa · people with sickle cell disease1 finding from 1 reviewHydroxyurea (hydroxycarbamide) for sickle cell disease 2022 · Cochrane Headline outcomes onlyno estimate extracted5 studies · 784 participantsModerate